SUMMARY In order to determine the mechanism of action of edrophonium on the cardiac conduction system, we used His bundle recording and pacing techniques to examinethe electrophysiological effect of edrophonium in 6 patients undergoing diagnostic evaluation for coronary artery disease and in 9 cardiac transplant recipients who were free of acute graft rejection. After control measurements were made of sinus cycle length, conduction intervals, and conduction system refractory periods, edrophonium was administered by constant intravenous infusion, and all electrophysiological measurements were repeated. In the normally innervated patients, edrophonium significantly increased sinus cycle length from 778 ± 21 ms to 883 ± 36 ms (P < 0 01), AH interval from 88 ± 11 ms to 100 ± 12 ms (P < 0.01), and AV nodal functional refractory period from 351 ± 44 ms to 391 + 36 ms (P < 0.05). In the patients with transplanted hearts, edrophonium had no electrophysiological effect other than increasing the cycle length ofthe remnant recipient atrium from 722 + 21 ms to 798 ± 31 ms (P < 0.01). We conclude that the electrophysiological effects of edrophonium in man are mediated primarily through autonomic innervation of the heart.
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Edrophonium is a drug with brief anticholinesterase physostigmine produce neuromuscular blockade in activity which is useful in the management of the rat phrenic nerve diaphragm preparation in the supraventricular tachyarrhythmias (Cantwell et al., absence of acetylcholine accumulation (Thesleff, 1972; Reddy et al., 1971) . Though the drug has 1960). Edrophonium may also have a non-autobeen used clinically for several decades, the specific nomically mediated direct cardiac effect, but this electrophysiological effects of edrophonium have possibility has not been studied. not been evaluated in humans.
In order to determine whether the electrophysioAnticholinesterase agents produce their para-logical effects of edrophonium are wholly dependent sympathomimetic effects by inhibiting acetyl on cardiac autonomic innervation, we studied the cholinesterase and allowing accumulation of acetyl effect of edrophonium on both the innervated and choline released from nerve endings (Koelle, 1975) . transplanted denervated human heart. Previous Many of these agents, however, also have im-investigations in cardiac transplant recipients have portant pharmacological effects that are at least shown that their hearts remain functionally partly independent of acetylcholinesterase inhibi-denervated and devoid of direct autonomic neural tion. For example, the ability of anticholinesterases influences after transplantation (Cannom et al., to reverse the neuromuscular blockade produced by 1973, 1975) . Thus, the cardiac transplant recipient curare is not quantitatively proportional to their provides an opportunity to study the possibility of anticholinesterase activity (Brimblecombe, 1974) . direct cardiac effects of edrophonium.
Neostigmine can produce contraction in muscle depleted of anticholinesterase by chronic denerva-Methods agents, or beta-blocking drugs. The 9 post-trans-leaving in situ the posterior walls of the right and plant patients were free from evidence of acute left atria to which the donor atria are anastomosed graft rejection or extracardiac disease, and the 6 (Stinson et al., 1969) . Thus, the transplant patients normally innervated subjects were undergoing have both donor and recipient activity which can be catheterisation for diagnostic evaluation of coronary recorded by surface and intracardiac techniques artery disease.
( Fig. 1) (Stinson et al., 1972) . Patients were catheterised in the postabsorptive Baseline recordings of the AH and HV intervals state under sedation with oral diazepam. A 7F and the sinus cycle length, including the recipient quadripolar recording-stimulating electrode catheter and donor sinus cycles in the transplant patients, was positioned in the high right atrium for atrial were made at the spontaneous and base-paced pacing and recording of the right atrial electro-heart rates (Rosen, 1972) . The sinus node recovery gram. In the cardiac transplant patients, the time was measured twice after atrial pacing at cycle catheter was positioned against the high antero-length of 430 ms for 1 minute, followed by abrupt lateral atrial wall to provide stable pacing of the termination of pacing. Atrial pacing was performed donor atrium. A 7F tripolar or a 5F bipolar elec-at decreasing cycle lengths of 400, 375, 350, 330, trode catheter was advanced across the tricuspid 315, and 300 ms until Wenckebach conduction valve for His bundle recording. Three surface occurred. The maximal cycle length at which electrocardiographic leads (I, aVF, and V1) were Wenckebach conduction was present was then recorded simultaneously with the intracardiac determined within 5 ms. electrograms and transmitted to the AC input of an
The atrial effective refractory period and the electrocardiographic amplifier with filter fre-effective and functional refractory periods of the quencies set between 40 and 500 Hz. Pacing atrioventricular node were determined using the stimuli of 2 ms in duration were delivered by a pro-extra stimulus technique with an underlying paced grammable digital stimulator (M. Bloom Asso-rhythm (Rosen, 1972) . The atrioventricular nodal ciates, Ltd., Narberth, Pennsylvania) at an amper-effective refractory period was taken as the longest age twice the diastolic threshold. Data were re-A1A2 interval at which A2 was not conducted to the corded on photographic paper at 100 mm/s paper His-Purkinje system. The atrioventricular nodal speed on a Hewlett-Packard recorder, Model No. functional refractory period was the shortest H1H2 4568C.
interval obtained. The AH interval during rapid During cardiac transplantation the recipient heart atrial pacing was recorded at the most rapid atrial is excised by division of the atria at their mid-level, rate at which there was one-to-one atrioventricular NX l f t k lili 0 X t, j4| Fig (Brimblecombe, 1974) . Because of to 167 with administration of edrophonium. the transient effect of a single intravenous dose of The mean atrioventricular nodal effective refracedrophonium, we have used a constant infusion of tory period was not significantly altered but the the drug to obtain a stable condition for electro-mean atrioventricular nodal functional refractory physiological measurements (Frieden et al., 1971) . period was prolonged by edrophonium from After resting control measurements were com-351 ±44 ms to 391 ±36 ms (P < 0'05). There was no pleted, each patient was given a test dose of 0 03 mg/kg of edrophonium, followed 1 minute later by an additional bolus of 0 07 mg/kg and a constant intravenous infusion of 0 14 mg/kg per min. The Table 1 Effects of edrophonium on innervated drug was infused for 10 minutes to achieve a stable patients condition. group.bmj.com on November 9, 2017 -Published by http://heart.bmj.com/ Downloaded from evidence of altered His-Purkinje conduction since different in slope and intercept (P<0.01). The the mean HV interval and QRS configuration and lower position of the refractory curve in the transduration were unchanged. plant patients is consistent with their lack of resting vagal tone. TRANSPLANT PATIENTS Fig. 3 shows the change in mean H1H2 response Table 2 summarises the effect of edrophonium in during edrophonium infusion. The linear rethe denervated hearts. Whereas the spontaneous gression curves in the innervated patients before recipient atrial cycle length was increased from 722 (R=0-829) and during (R=0-874) edrophonium are +21 ms to 798 ±31 ms (P < 001), the resting not significantly different, but two individual data donor atrial cycle length and atrial effective refrac-points at a premature A1A2 interval of 375 ms and tory period were unaffected. There was no change 450 ms show a significant prolongation of HjH2 in the AH interval during spontaneous rhythm and with edrophonium (P < 0.05). There were no sigrapid pacing, the longest pacing cycle length show-nificant differences in the transplant patients before ing Wenckebach conduction and the atrioventricu-and after edrophonium. lar nodal refractory periods. As in the innervated patients, His-Purkinje conduction remained un-SIDE EFFECTS changed.
The known side-effects of edrophonium include Fig. 2 illustrates the mean H1H2 interval at each nausea, abdominal pain, sweating, muscle fasci-A1A2 interval for both the control and transplant culations, visual blurring, increased bronchial patients before drug administration. Each point secretions, and salivation (Randall et al., 1955) . Only represents the mean for at least 4 patients for which 5 of our 15 patients experienced no side effects data at the given A1A2 interval (+t5 ms) were avail-(3 from the innervated group and 2 from the Al A2 (ms) Fig. 3 The effect of edrophonium on the mean HH12 Fig. 2 A plot of the mean HH12 and A1A2 intervals in interval at various premnature A1A2 intervals in the innervated and denervated patients. The innervated innervated and denervated patients. Edrophonium has patients have significantly longer H1H2 intervals no effect on the denervated group of patients, but tends consistent with the influence of resting vagal tone. See to prolong the H1H2 intervals in the innervated group.
text for details.
See text for details.
group.bmj.com on November 9, 2017 -Published by http://heart.bmj.com/ Downloaded from D. R. Stemple, R. . C. Hall, J. W. Mason, and D. C. Harrison: at least mild nausea. In addition, 1 had stomach The present study provides further evidence for thecramps, 2 complained of a tingling sensation in the predominant influence of resting vagal tone in the lower extremities, and 5 became diaphoretic. In no innervated heart. Fig. 2 shows a significantly larger patient were the side effects severe enough to stop H1H2 interval for each premature stimulus interval the study.
in the innervated group of patients compared with the denervated group. Thus, under control con-.
Discussion ditions, at any given premature pacing interval (A1A2) there is a slower conduction of the preOur results show that, at the dosage used in this mature stimulus (longer A2H2) in the innervated study, the effects of edrophonium on the cardiac patients.' This slowed conduction is characteristic conducting system are solely autonomically of enhanced parasympathetic stimulation (Higgins mediated; no direct effect of edrophonium on the et al. , 1973) . denervated human heart could be detected. Slowing Kolman et al. (1975) have emphasised that the of the innervated recipient atrial rate in the trans-effect of a vagotonic intervention is influenced plant patient group indicates that a pharmaco-greatly by pre-existing autonomic tone. For logically active dose of the drug was administered. example, vagal stimulation increases ventricular However, the possibility that a higher dose may fibrillation threshold only during a period of inhave significant, direct electrophysiological effects creased sympathetic activity. Similarly, the eleccannot be excluded.
trophysiological effects of edrophonium may be The electrophysiological effects of edrophonium more pronounced when the resting sympathetic which we determined in this study are consistent input is raised, and less pronounced in a state of with the known effects of cardiac parasympathetic low sympathetic tone. stimulation: slowing of the sinoatrial rate,
The duration of action of a single intravenous decrease of atrioventricular nodal conduction bolus of edrophonium is brief because of its comvelocity, and increase in atrioventricular nodal petitive displacement from acetylcholinesterase by refractoriness (Higgins et al., 1973) . These acetylcholine (Brimblecombe, 1974) . In this ineffects are also in keeping with the cardiac distribu-vestigation, we assumed that a stable condition was tion of cholinergic fibres which are richly supplied achieved by administration of a loading bolus of to the sinoatrial and atrioventricular nodal areas. edrophonium followed by a 10-minute infusion. Though cholinergic fibres have also been shown to However, plasma concentrations of edrophonium supply the ventricular specialised conducting were not measured to document a steady-state consystem, their experimentally measurable effect has dition. Previous studies in normal Wistar rats been primarily on the ventricular fibrillation showed the plasma half-life of the slow disposition threshold rather than conduction velocity per se phase of edrophonium elimination to be 68 minutes (Kent et al., 1974) . The lack of any measured effect (Back and Calvey, 1974) . On this basis, prolonged of edrophonium in the denervated heart suggests infusion of the drug could possibly cause accumulathe absence of any functionally active post-gang-tion and toxic plasma levels. However, in our lionic cholinergic fibres. Thus, there is no local studies, no late toxicity was noted during constant accumulation of acetylcholine to produce the para-intravenous infusion of up to one hour in duration. sympathomimetic effect seen in the innervated This investigation describes the electrophysioheart. logical effect of edrophonium on the innervated In patients subjected to remeasurement of atrio-human heart and shows that an identical dose proventricular nodal refractory periods, the functional duces no significant effect in the transplanted refractory period has been reported to vary signi-denervated heart, confirming for the first time that ficantly with time (Reddy et al., 1975) . Our finding the cardiac conduction system effects of edrothat the atrioventricular nodal functional refractory phonium in man are mediated by autonomic innerperiod was affected by edrophonium more than the vation of the heart. atrioventricular nodal effective refractory period suggests that the finctional refractory period is References more susceptible to autonomic influences, which may account for its previously observed spon- Back, D. J., and Calvey, T. N. (1974 
